Labyrinth of pills representing mental health challenges for individuals with intellectual disabilities.

Unnecessary Antipsychotics? Rethinking Mental Health Care for Adults with Intellectual Disabilities

Reese Marlowe in Health & Wellness December 2025 • 4 min read.

"New study reveals the over-prescription of antipsychotic medications for individuals with intellectual and developmental disabilities, sparking calls for more appropriate and monitored care."

For adults facing intellectual and developmental disabilities (IDD), mental health care can be a complex landscape. While medication sometimes plays a necessary role, a recent study published in The Canadian Journal of Psychiatry has shed light on a potentially troubling trend: the over-prescription of antipsychotic drugs to adults with IDD, even when a clear psychiatric need isn't evident. This prompts a critical examination of how we approach mental health support for this vulnerable population.

Antipsychotic medications are powerful drugs typically used to treat conditions like schizophrenia or bipolar disorder. However, their use in individuals with IDD, particularly when a co-occurring mental health condition is absent, is a subject of growing concern. These medications carry the risk of significant side effects, and questions remain about their effectiveness in managing behavioral challenges that may stem from other sources.

The study's findings highlight the urgent need for a more nuanced and cautious approach to prescribing antipsychotics for adults with IDD. It calls for greater attention to proper diagnosis, comprehensive assessment of underlying causes for behavioral issues, and exploration of alternative therapies. Let's delve into the details of this research and explore the implications for improving mental health care within the IDD community.

The Shocking Numbers: How Common is Antipsychotic Use in Adults with IDD?

Labyrinth of pills representing mental health challenges for individuals with intellectual disabilities.

The Canadian study paints a concerning picture of antipsychotic medication use among adults with IDD. Researchers analyzed data from over 51,000 adults with IDD in Ontario, Canada, tracking their medication use over a six-year period. The results revealed that:

These statistics underscore a significant reliance on antipsychotic medications within the IDD population, prompting questions about whether these drugs are always the most appropriate or necessary intervention.

Nearly 40% of adults with IDD were dispensed an antipsychotic medication during the study period.
In group homes, the rate was even higher, with over 56% of residents receiving antipsychotics.
Almost 30% of those prescribed antipsychotics did not have a documented psychiatric diagnosis.

One of the most alarming findings was that a significant percentage of adults with IDD were receiving antipsychotics without a corresponding psychiatric diagnosis. This raises serious concerns about potential off-label use of these medications to manage behavioral issues that may not be directly related to a mental health condition. For example, behaviors that are resulting from communications issues or lack of environmental support.

A Call for Change: Rethinking Mental Healthcare for Adults with IDD

The study's findings serve as a powerful reminder of the need for a more holistic and individualized approach to mental health care for adults with IDD. Over-reliance on medication, especially in the absence of a clear psychiatric diagnosis, can have detrimental consequences. The path forward involves:

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is the main concern regarding antipsychotic medication use in adults with Intellectual and Developmental Disabilities (IDD)?

The primary concern is the over-prescription of antipsychotic medications to adults with Intellectual and Developmental Disabilities (IDD), often without a clear psychiatric diagnosis. This practice raises questions about whether these powerful drugs are being used appropriately and whether the potential risks of side effects outweigh the benefits, particularly when alternative therapies might be more suitable for addressing behavioral challenges. This concern is highlighted by the study revealing nearly 30% of adults with IDD receiving antipsychotics without a documented psychiatric diagnosis, and over 56% in group homes. This situation calls for a reassessment of mental healthcare approaches within the IDD community.

What are the potential risks associated with the use of antipsychotic medications in individuals with IDD?

Antipsychotic medications, typically used for conditions like schizophrenia or bipolar disorder, carry the risk of significant side effects. When prescribed to individuals with Intellectual and Developmental Disabilities (IDD), especially when a co-occurring mental health condition isn't evident, these risks become a greater concern. The side effects can include a range of physical and neurological issues, potentially affecting the overall well-being and quality of life. These can also include metabolic changes and movement disorders. The long-term effects of antipsychotic use in individuals with IDD, particularly in the absence of a clear need, are not fully understood, adding to the apprehension surrounding their widespread use.

What did the Canadian study reveal about the use of antipsychotics among adults with IDD?

The Canadian study, published in *The Canadian Journal of Psychiatry*, uncovered a concerning pattern of antipsychotic medication use among adults with Intellectual and Developmental Disabilities (IDD). The study analyzed data from over 51,000 adults with IDD in Ontario, Canada, and revealed that nearly 40% of these individuals were dispensed an antipsychotic medication over a six-year period. The rate was even higher in group homes, with over 56% of residents receiving antipsychotics. Furthermore, almost 30% of those prescribed antipsychotics did not have a documented psychiatric diagnosis. These findings underscore the widespread use of these medications within the IDD population and raise questions about the appropriateness of these prescriptions.

What alternative approaches are suggested to improve mental healthcare for adults with IDD?

The study calls for a more holistic and individualized approach to mental health care for adults with Intellectual and Developmental Disabilities (IDD). The shift involves a greater focus on proper diagnosis, ensuring a thorough assessment to determine the underlying causes of behavioral issues. This may require environmental changes or support. It also encourages the exploration of alternative therapies, such as behavioral interventions, counseling, and environmental adjustments, before resorting to medication. This comprehensive approach aims to address the unique needs of each individual with IDD, minimizing reliance on antipsychotics and promoting better mental health outcomes by implementing changes at the system level.

How does the absence of a psychiatric diagnosis impact the use of antipsychotics in individuals with IDD?

The absence of a clear psychiatric diagnosis is a significant concern when prescribing antipsychotics to adults with Intellectual and Developmental Disabilities (IDD). The study revealed that a substantial percentage of individuals were receiving these medications without a documented psychiatric need. This raises concerns about the potential for off-label use, where the drugs are used to manage behavioral issues that may not be directly related to a mental health condition. This practice raises ethical questions and highlights the need for a more cautious and evidence-based approach. It underscores the importance of identifying the root causes of behavioral challenges through comprehensive assessments and exploring alternative interventions before considering antipsychotic medications. This will ensure the most appropriate and beneficial treatment plan.